In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Morphochem acquires Small Molecule Therapeutics

Executive Summary

Morphochem (creates chemical libraries) has acquired Small Molecule Therapeutics (cell-based technologies to determine protein-protein interactions) in order to become a fully integrated drug discovery company that combines biology and chemistry with chemical genomics. Morphochem acquired SMT's shares for cash and Morphochem stock.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Payment Includes Stock
    • Reverse Acquisition

Related Companies